Basic Information
Rezivertinib Mesylate Capsules
甲磺酸瑞齐替尼胶囊
瑞必达
30mg(按C₂₇H₃₀N₆O₃计)
胶囊剂
Regulatory Information
国药准字H20240017
Approved
化学药品
May 15, 2024
Product approved by National Medical Products Administration (CN)
Rezivertinib Mesylate Capsules
甲磺酸瑞齐替尼胶囊
瑞必达
30mg(按C₂₇H₃₀N₆O₃计)
胶囊剂
国药准字H20240017
化学药品
May 15, 2024